¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Nuclear Regulatory Commission"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nuclear feeling
    Çٽɰ¨Á¤
  • nuclear fission
    Çٺп­
  • nuclear isomer
    ÇÙÀ̼ºÃ¼
  • nuclear isomerism
    ÇÙÀ̼º
  • nuclear jaundice
    ÇÙȲ´Þ
  • nuclear magnetic resonance
    ÇÙÀÚ±â°ø¸í
  • nuclear magnetic resonance spectroscopy
    ÇÙÀÚ±â°ø¸íºÐ±¤¹ý
  • nuclear medicine
    ÇÙÀÇÇÐ
  • nuclear membrane
    ÇÙ¸·
  • nuclear paralysis
    ÇÙ¼º¸¶ºñ
  • nuclear paramagnetic resonance
    ÇÙ»óÀÚ¼º°ø¸í
  • nuclear paramagnetism
    ÇÙ»óÀÚ¼º
  • nuclear physics
    ÇÙ¹°¸®ÇÐ
  • nuclear polyhedrosis virus
    ÇٴٸéüÇü¼º¹ÙÀÌ·¯½º
  • nuclear pore
    ÇÙ±¸¸Û
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nuclear isomer
    ÇÙÀ̼ºÃ¼
  • nuclear isomerism
    ÇÙÀ̼º
  • nuclear jaundice
    (¢¡kernicterus) ÇÙȲ´Þ
  • net nuclear magnetization
    ÃÑÇÙÀÚ±âÈ­
  • nuclear medicine
    ÇÙÀÇÇÐ
  • nuclear membrane
    ÇÙ¸·
  • nuclear myopia
    ¼öÁ¤Ã¼ÇٱٽÃ
  • nuclear paralysis
    ÇÙ¼º¸¶ºñ
  • nuclear paramagnetism
    ÇÙ»óÀÚ¼º
  • nuclear physics
    ÇÙ¹°¸®ÇÐ
  • nuclear pore
    ÇÙ±¸¸Û, ÇÙ¸·±¸¸Û
  • nuclear radius
    Çٹݰæ
  • nuclear sap
    (¢¡karyolymph) ÇÙÁó
  • nuclear sclerosis
    ¼öÁ¤Ã¼ÇÙ°æÈ­
  • nuclear segmentation
    ÇÙºÐÇÒ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ ÇÙ¼º ¾È±Ù¸¶ºñ(òäú¼àõ ú·àõ äÑÐÉØ¦Ýö)
  • progressive nuclear ophthalmoplegia
    ÁøÇ༺ÇÙ¼º¾È±Ù¸¶ºñ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diaphragm of nuclear pore
    ÇÙ±¸¸Û°¡·Î¸·
  • external nuclear membrane
    ¹Ù±ùÇÙ¸·
  • extractable nuclear antigen
    ÃßÃâ°¡´ÉÇÙÇ׿ø
  • extractable nuclear antigen
    ÃßÃâ°¡´ÉÇÙ Ç׿ø
  • hypochromatosis =nuclear solution
    (ÇÙ)¿°Áú°¨¾à(ú·æøòõÊõå°) ÇÙºØA , ÇǺλö¼ÒÄ§Âø°¨¼ÒÁõ(ù«Ý±ßäáÈ ó·Êõá´ñø).
  • inner nuclear layer
    ³»ÇÙÃþ(Ò®ú·öµ).
  • inner nuclear layer
    ¼ÓÇÙÃþ
  • inner nuclear layer
    ³»°ú¸³Ãþ(Ò®öµ), ¼ÓÇÙÃþ.
  • internal nuclear layer bipolar cell layer
    ¼ÓÇÙÃþ µÎ±Ø¼¼Æ÷Ãþ
  • internal nuclear membrane
    ¼ÓÇÙ¸·
  • karyolymph =nuclear sap
    ÇÙ¾×(ú·äû).
  • net nuclear magnetization
    ÃÑ ÇÙÀÚ±âÈ­
  • nuclear antibody.
    ÇÙÇ×ü
  • nuclear antigen
    ÇÙÇ׿ø
  • nuclear bag
    ÇÙ³¶(ú·Ò¥).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Fourier transform nuclear magnetic resonance
    Ǫ¸®¿¡ º¯È¯(ܨüµ) ÇÙÀÚ±â°ø¸í(ú·í¸Ñ¨ÍìÙ°)
  • heterogeneous nuclear RNA
    ÀÌÁú(ì¶òõ) ÇÙ(ú·)RNA
  • nuclear body
    ÇÙü(ú·ô÷)
  • nuclear column
    ÇÙ(ú·) Ä÷³
  • nuclear cycle
    ÇÙÁÖ±â(ú·ñÎÑ¢)
  • nuclear division
    Çٺп­(ú·ÝÂÖª)
  • nuclear duplication
    ÇÙº¹»ç(ú·ÜÜÞÐ)
  • nuclear emulsion
    ÇÙ(ú·)¿¡¸ÖÀü
  • nuclear envelope
    ÇÙ¸·(ú·Ø¯)
  • nuclear equivalent
    ÇÙ´çü(ú·Ó×ô÷)
  • nuclear fission
    Çٺп­(ú·ÝÂÖª)
  • nuclear fusion
    ÇÙÀ¶ÇÕ(ú·ë×ùê)
  • nuclear isomer
    ÇÙÀ̼ºÃ¼(ú·ì¶àõô÷)
  • nuclear magnetic resonance
    ÇÙÀÚ±â°ø¸í(ú·í¸ÐïÍìÙ°)
  • nuclear resonance scattering
    ÇÙ°ø¸íºÐ»ê(ú·ÍìÙ°ÝÂߤ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IRTU integrating regulatory transcription unit
MRF Markov random field; medical record file; melanocyte-[stimulating hormone]-releasing factor; mesence...
PRKAR protein kinase, cyclic adenosine monophosphate-dependent, regulatory
PRKAR1A protein kinase, cyclic adenosine monophosphate-dependent, regulatory, type 1 alpha
RH radiant heat; radiation hybrid; radiological health; reactive hyperemia; recurrent herpes; regulator...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EEOC Equal Employment Opportunity Commission
EC European Commission
"FTC" Federal Trade Commission
HIC Health Insurance Commission
ICRU International Commission of Radiation Units and Measurements
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nuclear model
    ÇÙ ¸ðÇü
  • nuclear paramagnetism
    ÇÙ»ó ÀÚ¼º
  • nuclear physics
    ÇÙ ¹°¸®ÇÐ
  • nuclear power
    ÇÙ ·Â
  • nuclear radius
    ÇÙ ¹Ý°æ
  • nuclear rest
    ÇÙ ÈÞÁö
  • nuclear schizophrenia
    ÇÙ Á¤½ÅºÐ¿­Áõ
  • nuclear shift
    ÇÙ À̵¿
  • Pelger's nuclear anomaly
    Æç°Å ÇÙ ÀÌ»ó
    È£Áß±¸¿Í È£»ê±¸ÀÇ Á¤»ó ÇÙ ºÐ¿±À» ¹æÇØÇÏ´Â À¯Àü¼º °áÇÔ. ÇÙÀÌ °£»ó, ±¸»ó, ¾Æ·É»óÀ¸·Î µÈ´Ù.
  • pontine nuclear atrophy
    ³ú±³ ÇÙÀÇ À§Ãà
  • posterior nuclear group
    ÈÄÇÙ Áý´Ü
  • vesitibular nuclear complex
    ÀüÁ¤½Å°æ ÇÙ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
regulatory sequence <molecular biology> DNA sequence to which regulatory molecules such as promotors or enhancers bind, thereby altering the expression of the adjacent gene.
(18 Nov 1997)
regulatory sequences, nucleic acid DNA sequences involved in regulating the expression of other genes.
(12 Dec 1998)
regulatory T-cell <immunology> Vague term for any class of T lymphocyte not directly involved in the effector side of immunity, but involved in controlling responses and actions of other cells, especially T helper and T suppressor cells.
(18 Nov 1997)
myogenic regulatory factors A family of muscle-specific transcription factors which bind to DNA in control regions and thus regulate myogenesis. All members of this family contain a conserved helix-loop-helix motif which is homologous to the myc family proteins. These factors are only found in skeletal muscle. Members include the myod protein (myod protein), myogenin, myf-5, and myf-6 (also called mrf4 or herculin).
(12 Dec 1998)
public utility regulatory policies act (PURPA) A federal law requiring a utility to buy the power produced by a qualifying facility at a price equal to that which the utility would otherwise pay if it were to build its own power plant or buy power from another source.
(05 Dec 1998)
sequence, regulatory A sequence of bases in DNA that controls the expression of a gene.
(12 Dec 1998)
receptors, cytoplasmic and nuclear Proteins in the cytoplasm or nucleus that specifically bind signalling molecules and trigger changes which influence the behaviour of cells. The major groups are the steroid hormone receptors, which usually are found in the cytoplasm, and the thyroid hormone receptors, which usually are found in the nucleus. Receptors, unlike enzymes, generally do not catalyze chemical changes in their ligands.
(12 Dec 1998)
Remak's nuclear division <cell biology> An unusual form of nuclear division, in which the nucleus simply constricts, rather like a cell without chromosome condensation or spindle formation. Partitioning of daughter chromosomes is haphazard. Observed in some Protozoa.
(18 Nov 1997)
Pelger-Huet nuclear anomaly Congenital inhibition of lobulation in the nuclei of neutrophilic leukocytes; most cells present band or bilobulate appearance, and only an occasional cell is trilobed; it is not associated with disease, but may be confused with leukocyte "shift to left"; autosomal dominant inheritance.
(05 Mar 2000)
ribonucleoproteins, small nuclear Highly conserved nuclear RNA-protein complexes that function in RNA processing in the nucleus, including pre-mRNA splicing and pre-mRNA 3'-end processing in the nucleoplasm. The u3 snrnp is localised in the nucleolus, where it aligns into base pairs with the 28s rrna precursor in a still unidentified region and functions in pre-rrna processing. The u7 snrnp aligns into base pairs with a conserved sequence in the 3'-end of histone pre-mRNA and is an essential cofactor for the cleavage that creates the mature nonadenylated 3'-end.
(12 Dec 1998)
RNA, heterogeneous nuclear Nuclear nonribosomal RNA larger than about 1000 nucleotides, the mass of which is rapidly synthesised and degraded within the cell nucleus. Some heterogeneous nuclear RNA may be a precursor to mRNA. However, the great bulk of total hnrna hybridises with nuclear DNA rather than with mRNA.
(12 Dec 1998)
RNA, nuclear RNA molecules found in the nucleus either associated with chromosomes or in the nucleoplasm.
(12 Dec 1998)
RNA, small nuclear Short chains of RNA found in the nucleus. Their function is to remove the introns (nontranslated intervening sequences) from mRNA precursors, thereby bringing the two exons (coding segments) together into correct juxtaposition for enzymatic splicing at the correct point. The resulting mRNA is now ready to leave the nucleus.
(12 Dec 1998)
rod nuclear cell <pathology> Immature neutrophils released from the bone marrow reserve in response to acute demand.
(18 Nov 1997)
cistern of nuclear envelope The space between the internal and external membranes of the nuclear envelope; may be continuous in places with cisterns of the endoplasmic reticulum.
Synonym: cistern of nuclear envelope, perinuclear space.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • commission merchant
    À§Å¹ÆÇ¸ÅÀÎ;Á߸ÅÀÎ
  • commission plan
    À§¿øÈ¸Á¦(½ÃÀÇ ÀÔ¹ý.ÇàÁ¤ Àü¹ÝÀ» À§¿øÈ¸°¡ ó¸®ÇÏ´À)
  • commission sale
    À§Å¹ÆÇ¸Å
  • roving commission
    (Á¶»ç¿ø µîÀÇ)ÀÚÀ¯¿©Çà±ÇÇÑ;¿©±âÀú±â ¶Ù¾î´Ù´Ï´Â ¾÷¹«
  • nuclear
    (»ý)¼¼Æ÷ÇÙÀÇ;ÇÙÀ» Çü¼ºÇÏ´Â;¿øÀÚÇÙ·ÂÀÇ;¿øÀÚ¹«±âÀÇ;ÇÙ¹«±âÀÇ;ÇÙº¸À¯ÀÇ;ÇÙ½ÉÀÇ;ÁÖ¿äÇÑ;ÇÙ¹«±â;ÇÙº¸À¯±¹
  • nuclear bomb
    ÇÙÆøÅº
  • nuclear chemistry
    ÇÙÈ­ÇÐ
  • nuclear disarmament
    ÇÙ±ºÃà
  • nuclear energy
    ÇÙ ¿¡³ÊÁö !
  • nuclear failout
    ÇÙ Æø¹ß¿¡ ÀÇÇÑ ¹æ»ç´É ³«Áø
  • nuclear family
    ÇÙ°¡Á·
  • nuclear fission
    Çٺп­
  • nuclear force
    ÇÙ·Â
  • nuclear fuel
    ÇÙ¿¬·á
  • nuclear fusion
    ÇÙÀ¶ÇÕ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á